← Back
$PRME All transactions

Prime Medicine, Inc.

▲ BUY
9 / 10

Conviction

$ Value

$147K

Shares

125,000

Price

$1

Filed

May 22

Why this score? (9/10)
  • Open market buy (+3)
  • C-suite insider (+2)
  • Director (+1)
  • Cluster: 3 insiders buying (+2)
  • Not a 10b5-1 plan (+1)

Insider

Name

Reine Allan

Title

Chief Executive Officer

CIK

0001714023

Roles

Director Officer

Transaction Details

Transaction Date

2025-05-21

Code

P

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

125,000

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.13 to $1.20, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer or the staff of the Securities and Exchange Commission, upon request, information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Filing Info

Accession No.

0001894562-25-000026

Form Type

4

Issuer CIK

0001894562

Reine Allan's History

Date Ticker Type Value
2025-08-01 PRME D
2025-08-01 PRME A
2025-05-21 PRME $147K
2025-05-19 PRME A $0
2025-05-08 PRME A $0

Other Insiders at PRME (90d)

Insider Bought Sold Last
Makhni Svetlana Ni
Chief Financial Officer
2026-04-16